Keytruda is a medication that has demonstrated remarkable effectiveness in treating a variety of cancers, including lung cancer, melanoma, and lymphoma, among others. To promote its drug, Keytruda has recently launched a new TV spot called "It's TRU: Roger's Story: Living Longer Is Possible."
In the TV spot, we meet Roger, a man who has been diagnosed with advanced non-small cell lung cancer. Roger describes how he is determined to do everything he can to fight his disease and live longer, including taking Keytruda, which he calls "a game-changer."
Roger's story is inspiring and hopeful, as we see him enjoying time with his family and pursuing the things he loves despite his diagnosis. He credits Keytruda with enabling him to continue living his life to the fullest.
The TV spot is well-crafted and effective at conveying the benefits of Keytruda without being overly promotional. It's clear that the focus of the ad is on Roger's story and the hope that Keytruda has given him, rather than simply touting the drug's efficacy.
Overall, the "It's TRU: Roger's Story: Living Longer Is Possible" TV spot is a powerful and emotional piece that highlights the potential benefits of Keytruda for people who are living with advanced cancer. It carries an important message of hope and determination, showing that with the right treatment options, living a full and meaningful life is still possible.
Keytruda TV commercial - Its TRU: Rogers Story: Living Longer Is Possible produced for Keytruda was first shown on television on September 9, 2018.
We analyzed TV commercials placed on popular platforms and found the most relevant videos for you:
Keytruda is a brand name for pembrolizumab, an immunotherapy drug developed and marketed by Merck & Co. It was approved by the U.S. Food and Drug Administration (FDA) in 2014 for the treatment of adva...
A company initiative is a pro-active effort undertaken by a business to achieve a specific objective or goal. These initiatives can vary widely in scope and focus, including everything from internal p...